YD Bio Limited (YDES)
Nasdaq: YDES · Services-Medical Laboratories · Irving, TX · filing with the SEC since 2024
Who owns YD Bio Limited
As filed with the SECHolders of 5% or more
1
Ethan Shen holds 77.1% of Ordinary Shares, par value of US$0.0001 per share, as its SCHEDULE 13G/A filed Feb 17, 2026 says.
Directors and officers
6
report now, of 6 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Ethan Shen
SCHEDULE 13G/A · filed Feb 17, 2026 · Ordinary Shares, par value of US$0.0001 per share · 77.1% in Dec 16, 2025
What YDES reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
YDBiopharma
A company bought · acquisition · owns, named in the 20-F filed Apr 30, 2026
4 subsidiaries in 4 countries, from the list filed with the 20-F filed Apr 30, 2026.
Insider tradesForm 4
0sales
3purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Oct 6, 2025 to Oct 6, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 6, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 6 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Shen Ethan Phd | CEO | 0 | $0 | 0 | 3 | $100,000 |